11/18
08:00 am
gdtc
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
Low
Report
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
11/6
08:00 am
gdtc
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
High
Report
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
10/22
08:00 am
gdtc
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%
Low
Report
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%
10/15
08:48 am
gdtc
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
Medium
Report
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
10/15
08:45 am
gdtc
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
Medium
Report
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
10/14
08:00 am
gdtc
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
Low
Report
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
10/2
07:00 am
gdtc
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic ?d T Cells in Acute Myeloid Leukemia
Medium
Report
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic ?d T Cells in Acute Myeloid Leukemia